Format
Sort by

Send to

Choose Destination

Search results

Items: 7

1.

Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations.

Baker CJ.

J Adolesc Health. 2016 Aug;59(2 Suppl):S29-37. doi: 10.1016/j.jadohealth.2016.03.040. Review.

2.

Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Zhang L, Li Z, Wan Z, Kilby A, Kilby JM, Jiang W.

Vaccine. 2015 Aug 26;33(36):4430-6. doi: 10.1016/j.vaccine.2015.06.077. Review.

3.

Vaccines against invasive Salmonella disease: current status and future directions.

MacLennan CA, Martin LB, Micoli F.

Hum Vaccin Immunother. 2014;10(6):1478-93. doi: 10.4161/hv.29054. Review.

4.

The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countries.

Musher DM, Rodriguez-Barradas MC.

Hum Vaccin Immunother. 2014;10(5):1331-3. doi: 10.4161/hv.29031. Review.

5.

Development of Vi conjugate - a new generation of typhoid vaccine.

Szu SC.

Expert Rev Vaccines. 2013 Nov;12(11):1273-86. doi: 10.1586/14760584.2013.845529. Review.

PMID:
24156285
6.

Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012.

Jones C, Lee CK, Ahn C, Shin J, Knezevic I.

Vaccine. 2013 Sep 23;31(41):4466-9. doi: 10.1016/j.vaccine.2013.07.070.

PMID:
23933367
7.

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

Simon R, Levine MM.

Hum Vaccin Immunother. 2012 Apr;8(4):494-8. doi: 10.4161/hv.19158. Review.

Items per page

Supplemental Content

Loading ...
Support Center